Literature DB >> 12161559

Transplanting allosteric control of enzyme activity by protein-protein interactions: coupling a regulatory site to the conserved catalytic core.

Aaron C Pawlyk1, Donald W Pettigrew.   

Abstract

Glycerol kinase from Escherichia coli, but not Haemophilus influenzae, is inhibited allosterically by phosphotransferase system protein IIA(Glc). The primary structures of these related kinases contain 501 amino acids, differing at 117. IIA(Glc) inhibition is transplanted from E. coli glycerol kinase into H. influenzae glycerol kinase by interconverting only 11 of the differences: 8 residues that interact with IIA(Glc) at the allosteric binding site and 3 residues in the conserved ATPase catalytic core that do not interact with IIA(Glc) but the solvent accessible surface of which decreases when it binds. The three core residues are crucial for coupling the allosteric site to the conserved catalytic core of the enzyme. The site of the coupling residues identifies a regulatory locus in the sugar kinase/heat shock protein 70/actin superfamily and suggests relations between allosteric regulation and the active site closure that characterizes the family. The location of the coupling residues provides empirical validation of a computational model that predicts a coupling pathway between the IIA(Glc)-binding site and the active site [Luque, I. & Freire, E. (2000) Proteins Struct. Funct. Genet. Suppl. 4, 63-71]. The requirement for changes in core residues to couple the allosteric and active sites and switching from inhibition to activation by a single amino acid change are consistent with a postulated mechanism for molecular evolution of allosteric regulation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12161559      PMCID: PMC123219          DOI: 10.1073/pnas.132393599

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  Structural stability of binding sites: consequences for binding affinity and allosteric effects.

Authors:  I Luque; E Freire
Journal:  Proteins       Date:  2000

2.  Escherichia coli glycerol kinase. Cloning and sequencing of the glpK gene and the primary structure of the enzyme.

Authors:  D W Pettigrew; D P Ma; C A Conrad; J R Johnson
Journal:  J Biol Chem       Date:  1988-01-05       Impact factor: 5.157

3.  Subunit dissociation in the allosteric regulation of glycerol kinase from Escherichia coli. 2. Physical evidence.

Authors:  J K de Riel; H Paulus
Journal:  Biochemistry       Date:  1978-11-28       Impact factor: 3.162

4.  IIA(Glc) allosteric control of Escherichia coli glycerol kinase: binding site cooperative transitions and cation-promoted association by Zinc(II).

Authors:  C K Holtman; A C Pawlyk; N Meadow; S Roseman; D W Pettigrew
Journal:  Biochemistry       Date:  2001-11-27       Impact factor: 3.162

5.  Subunit structure of L-ribulokinase from Escherichia coli.

Authors:  N Lee; J W Patrick; N B Barnes
Journal:  J Biol Chem       Date:  1970-03-25       Impact factor: 5.157

6.  The interpretation of protein structures: estimation of static accessibility.

Authors:  B Lee; F M Richards
Journal:  J Mol Biol       Date:  1971-02-14       Impact factor: 5.469

7.  Glycerol transport and phosphoenolpyruvate-dependent enzyme I- and HPr-catalysed phosphorylation of glycerol kinase in Thermus flavus.

Authors:  Emmanuelle Darbon; Kiyoshi Ito; Hua-Shan Huang; Tadashi Yoshimoto; Sandrine Poncet; Josef Deutscher
Journal:  Microbiology (Reading)       Date:  1999-11       Impact factor: 2.777

8.  Subcloning, expression, purification, and characterization of Haemophilus influenzae glycerol kinase.

Authors:  A C Pawlyk; D W Pettigrew
Journal:  Protein Expr Purif       Date:  2001-06       Impact factor: 1.650

9.  Reverse genetics of Escherichia coli glycerol kinase allosteric regulation and glucose control of glycerol utilization in vivo.

Authors:  C K Holtman; A C Pawlyk; N D Meadow; D W Pettigrew
Journal:  J Bacteriol       Date:  2001-06       Impact factor: 3.490

10.  A comprehensive two-hybrid analysis to explore the yeast protein interactome.

Authors:  T Ito; T Chiba; R Ozawa; M Yoshida; M Hattori; Y Sakaki
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

View more
  7 in total

1.  Functional consequences of exchanging domains between LacI and PurR are mediated by the intervening linker sequence.

Authors:  Sudheer Tungtur; Susan M Egan; Liskin Swint-Kruse
Journal:  Proteins       Date:  2007-07-01

Review 2.  What Mutagenesis Can and Cannot Reveal About Allostery.

Authors:  Gerald M Carlson; Aron W Fenton
Journal:  Biophys J       Date:  2016-05-10       Impact factor: 4.033

3.  Exploring modular allostery via interchangeable regulatory domains.

Authors:  Yifei Fan; Penelope J Cross; Geoffrey B Jameson; Emily J Parker
Journal:  Proc Natl Acad Sci U S A       Date:  2018-03-05       Impact factor: 11.205

4.  Amino acid substitutions in the sugar kinase/hsp70/actin superfamily conserved ATPase core of E. coli glycerol kinase modulate allosteric ligand affinity but do not alter allosteric coupling.

Authors:  Donald W Pettigrew
Journal:  Arch Biochem Biophys       Date:  2008-11-27       Impact factor: 4.013

5.  L-Rhamnose transport is sugar kinase (RhaK) dependent in Rhizobium leguminosarum bv. trifolii.

Authors:  Jason S Richardson; Ivan J Oresnik
Journal:  J Bacteriol       Date:  2007-09-21       Impact factor: 3.490

6.  Subdividing repressor function: DNA binding affinity, selectivity, and allostery can be altered by amino acid substitution of nonconserved residues in a LacI/GalR homologue.

Authors:  Hongli Zhan; Marc Taraban; Jill Trewhella; Liskin Swint-Kruse
Journal:  Biochemistry       Date:  2008-07-11       Impact factor: 3.162

7.  Oligomeric interactions provide alternatives to direct steric modes of control of sugar kinase/actin/hsp70 superfamily functions by heterotropic allosteric effectors: inhibition of E. coli glycerol kinase.

Authors:  Donald W Pettigrew
Journal:  Arch Biochem Biophys       Date:  2009-10-09       Impact factor: 4.013

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.